Loncar China BioPharma ETF (CHNA) |
| 13.53 -0.01 (-0.07%) 10-17 15:51 |
| Open: | 14.3 |
| High: | 14.3 |
| Low: | 13.53 |
| Volume: | 9 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 14.77 |
| Resistance 1: | 12.86 |
| Pivot price: | 12.66 |
| Support 1: | 9.77 |
| Support 2: | 8.13 |
| 52w High: | 22.89 |
| 52w Low: | 9.76966 |
The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 22 Nov 2022
The Nasdaq Golden Dragon is scorching November; China-themed ETFs are doing even better - Stockhead
Thu, 29 Apr 2021
Best Biotech Stocks & ETFs for mRNA, Gene Editing - Nasdaq
Sat, 13 Apr 2019
Chinese Biotech Is the Future - The Motley Fool
Fri, 10 Aug 2018
Chinese biotech and pharmaceuticals ETF - ETF Stream
Fri, 27 Feb 2026
Fri, 27 Feb 2026
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
